XRP Ignites DeFi Surge: Live on Injective as XRPL EVM Integration Unleashes Cross-Chain Firepower

XRP just cracked open the DeFi floodgates.

The digital asset—long confined to payment rails—is now live on Injective Protocol, riding the wave of XRPL's freshly launched Ethereum Virtual Machine (EVM) compatibility. This isn't just another listing—it's a liquidity superhighway connecting Ripple's ecosystem to Ethereum's sprawling DeFi landscape.

From Bridged to Unshackled

No more wrapping, no more middlemen. The EVM upgrade lets XRP holders bypass centralized exchanges entirely, swapping directly into yield farms, perpetuals, and options markets. Injective's orderbook infrastructure amplifies the play—zero gas fees meet institutional-grade liquidity.

The Institutional Angle

Watch for hedge funds to pile in. With XRP's regulatory clarity and now EVM composability, it's becoming the rare crypto that ticks both compliance and utility boxes. (Wall Street bankers still won't admit they're farming APY, though.)

This is cross-chain interoperability at warpspeed—and it's happening while legacy finance still struggles with SWIFT upgrades. The rails just got rewired.

TLDR

• Injective has integrated XRP following the launch of the XRP Ledger EVM sidechain.
• This makes Injective the first major blockchain to adopt the XRPL EVM mainnet.
• XRP gained 6.8 percent and reached a high of $2.319 before correcting to $2.19.
• XRP trading volume surged by 114 percent to reach $4.14 billion within 24 hours.
• INJ price dropped by 4.9 percent and is currently trading at $10.42.

Injective has officially integrated XRP following the launch of the XRP Ledger EVM sidechain. This makes Injective the first major blockchain to adopt the XRPL EVM mainnet. Despite this development, INJ recorded a 4.9% price drop in the past 24 hours.

The strategic MOVE introduces XRP into Injective’s ecosystem, enhancing its accessibility and utility in the decentralized finance space. XRP’s EVM compatibility has enabled smart contract functionality, driving increased adoption across blockchain networks. Meanwhile, trading volumes for XRP have sharply risen, contrasting INJ’s declining performance.

Institutional demand for XRP also continues to grow as more public companies add it to their treasury assets. At the same time, market reaction to Injective’s announcement remains mixed, reflecting investor uncertainty. Yet, both networks are seeing expanding use cases that may reshape their long-term value outlook.

XRP Integration Boosts Utility and Institutional Demand

XRP’s price surged by 6.8% to reach $2.319 after Injective announced support for the token via the XRPL EVM sidechain. The token was later corrected to $2.19, but it still posted a 1.13% daily gain. Its trading volume ROSE by 114%, reaching $4.14 billion, indicating increased market activity.

$XRP is now live on Injective!

Injective is the first major chain to integrate @peersyst’s XRPL's EVM mainnet, enabling a seamless gateway into one of the largest assets in all of crypto.

Welcome to a new future of onchain financial infrastructure. Welcome to Injective. https://t.co/Ay2ecRNLA5 pic.twitter.com/YMK27AixWu

— Injective 🥷 (@injective) June 30, 2025

This integration enhances XRP’s position in on-chain finance, expanding its reach into Ethereum-compatible ecosystems. The XRPL EVM sidechain now allows decentralized applications to utilize XRP natively within Injective. This move strengthens XRP’s utility for real-world use cases and developer access.

Several public companies have started adopting XRP as a strategic treasury asset, further validating its institutional relevance. Vivopower International raised $121 million to fund a $100 million XRP treasury strategy. The firm aims to become the first public company to center its financial model on XRP.

Other companies such as Worksport Ltd, Hyperscale Data Inc., and Webus International Ltd. have joined this trend. Webus International partnered with Samara Alpha to manage a $300 million XRP treasury. Wellgistics Health is also using XRP for real-time payments to eliminate banking delays.

INJ Price Drops Despite Strategic Expansion

INJ recorded a 4.9% drop in 24 hours, falling to $10.42 after reaching a daily high of $11.15. The price is down 10% this week and 11% over the past month. Trading volume also declined by 4.5%, totaling $82.36 million.

The token’s drop comes despite Injective’s significant partnership with Ripple and its adoption of the XRPL EVM mainnet. This suggests market sentiment remains cautious in the short term. However, the integration positions Injective for broader participation in Ethereum-compatible DeFi.